Cardiol Therapeutics

CRDLNasdaq Canada Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$228.048 M

$1.89 +1.61%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

100,257,009

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#91Anavex Life SciencesAVXL$229.0M
#92Protalix BioTherapeuticsPLX$228.8M
#93Cardiol TherapeuticsCRDL$228.0M
#94AlectorALEC$224.4M
#95Compass TherapeuticsCMPX$223.3M

What if Cardiol Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$250,570.68

Per share 132,577× higher

Bitcoin $1.74T

$14,434.35

Per share 7,637× higher

Nvidia $5.52T

$45,713.13

Per share 24,187× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Cardiol Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.